Evigrade

Folic acid

AEMPS

Vitamins. Haemopoietic stimulants

ATC code: B03BB01

Brand names – drugs: Folvite, Deplin

Brand names – supplements: Thorne 5-MTHF, Solgar FolateSupplements are not tested in clinical trials and are not registered as medications.

Updated · Methodology

Indications

A

Folate deficiency anaemia

First line

Folic acid 1–5 mg daily for 1–4 months is first-line for folate deficiency anaemia. Clinical response: reticulocyte crisis at 5–10 days, haemoglobin normalisation over 1–2 months. Co-existing B12 deficiency must be excluded before starting therapy – isolated folate use in unrecognised B12 deficiency masks anaemia but does not prevent neurological degeneration.

ICD-10: D52 · ICD-11: 3A02

A

Methotrexate-related adverse event prevention

First line

Concurrent folic acid 5 mg once weekly (day after methotrexate) is a required component of low-dose methotrexate therapy in rheumatoid arthritis, psoriatic arthritis, and psoriasis. 2023 includes folic acid in the standard protocol. Reduces hepatotoxicity, nausea, stomatitis, and cytopenias without compromising methotrexate's anti-inflammatory effect.

A

Neural tube defect prevention

First line

Folic acid 400 µg daily in all women planning pregnancy and through the first 12 weeks of pregnancy is foundational neural tube defect prevention. 2023 reaffirmed recommendation A. In women with a prior NTD pregnancy, diabetes, epilepsy, obesity, or on antiepileptics, the dose is increased to 4–5 mg daily. The Cochrane review confirmed a 70% reduction in open neural tube defects.

Supplementation starts 1–3 months before conception. Most NTDs form by day 28 of embryogenesis, before the woman may be aware of pregnancy.

ICD-10: Q05 · ICD-11: LA02

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

D

Anti-aging and longevity

Not recommended

Folic acid is a B vitamin needed for cell division and blood formation. For anti-aging and longevity it gets marketed as a supplement that supposedly slows aging and extends lifespan. No convincing benefit has been shown for this use: there is no evidence base supporting an anti-aging effect in people without a deficiency. Folic acid makes sense for a confirmed deficiency and when planning a pregnancy; for slowing aging, other approaches help – sleep, diet, physical activity, not smoking, and protecting skin from the sun.

D

Major depressive disorder

Not recommended

The 2019 Cochrane review (3 RCTs, 247 participants) did not find a clinically meaningful effect of folic acid or L-methylfolate as monotherapy or adjunct in major depression. Small positive RCTs in patients with folate deficiency or MTHFR polymorphism have not been reproduced. and mental health do not include folate in depression treatment standards.

ICD-10: F32.9 · ICD-11: 6A70.Z

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

Folic acid (vitamin B9) is reduced in the body to tetrahydrofolate – a one-carbon group carrier in purine, thymidine, and amino acid (methionine, serine, glycine) synthesis. Required for DNA synthesis and division of rapidly proliferating cells (bone marrow, GI epithelium, foetus). Deficiency causes megaloblastic anaemia and, in early embryogenesis, neural tube defects.

Safety

Contraindications

  • Hypersensitivity to folic acid
  • Untreated B12 deficiency anaemia (risk of masking and neurological progression)
  • Pernicious anaemia without B12 (same reason)
  • Malignancy (relative contraindication for high doses)

Serious adverse effects

  • Masking of B12 deficiency with progression of subacute combined degeneration
  • Anaphylactic reactions (very rare)

Common adverse effects

  • Epigastric discomfort at high doses
  • Altered taste

Uncommon adverse effects

  • Allergic reactions (urticaria, pruritus, bronchospasm)
  • Sleep disturbance, irritability at doses above 15 mg daily

Pregnancy: can you take Folic acid?

AEMPS summary of product characteristics (section 4.6): based on human experience, no risks of folic acid use in pregnancy are known, and folic acid supplements are usually beneficial. Folate deficiency not caused by drugs and abnormal folate metabolism are linked to birth defects, including some neural tube defects, and drug-induced interference with folic acid metabolism or folate deficiency early in pregnancy (anticonvulsants, some antineoplastics) leads to congenital anomalies. A lack of this vitamin or its metabolites may also be responsible for some cases of miscarriage and intrauterine growth restriction.

Breastfeeding: can you take Folic acid?

Transfers into breast milk. Supplementation at the RDA of 500 µg is safe and encouraged.

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Practical notes

Timing and administration

Take regardless of meals at any time of day. With methotrexate, take the day after methotrexate, not concurrently. Well absorbed from the small intestine regardless of pH.

Dose titration

NTD prevention: 400 µg daily, 4–5 mg daily in high-risk groups. Folate deficiency anaemia treatment: 1–5 mg daily for 1–4 months. With methotrexate: 5 mg once weekly. RDA for healthy adults: 400 µg.

Monitoring

In folate deficiency anaemia treatment, check reticulocytes at 1 week and haemoglobin and MCV at 4 weeks. Before prescribing high-dose folic acid, exclude concurrent B12 deficiency – check serum B12 or methylmalonic acid. In pregnant women on standard prophylactic doses, no additional monitoring is needed.

Food and drinks

Dietary sources: green leafy vegetables (spinach, chard), legumes (lentils, chickpeas), citrus, avocado, liver. Natural folates degrade during cooking (30–60% loss). Synthetic folic acid from fortified foods and supplements is 85% bioavailable, natural folate 50%. In women with MTHFR polymorphism, L-methylfolate is sometimes considered – but routine genotyping is not required, as 5 mg folic acid provides sufficient active form.

Common myths

Myth: “folic acid is only for pregnant women”. Fact: supplementation is recommended for all women of reproductive age who may become pregnant – most unintended pregnancies are unplanned, and the critical neural tube window is the first 28 days.

Myth: “methylfolate is better than folic acid for everyone”. Fact: for most women, folic acid 400 µg is fully effective. Methylfolate costs 5–10 times more without proven advantage in general populations. There may be benefit in women with homozygous MTHFR polymorphism and high homocysteine – but this is a narrow group.


Myth: “folic acid causes cancer”. Fact: there are observational data linking high doses with progression of pre-existing tumours in older adults – clinically significant effect not confirmed. In reproductive-age women at prophylactic doses, cancer risk is not increased.

Drug–drug interactions

1 pair found. Sorted from critical to minor.

MinorMetforminBiguanides. Oral antihyperglycemic agents

Mechanism

Metformin on long-term use (over 5 years) moderately reduces blood B12 (by 10–30%). Effect on folate is minimal. Folate deficiency on metformin has not been described.

Symptoms

The combination usually causes no specific symptoms. Each drug's individual side effects remain.

Management

No folate dose adjustment needed. On long-term metformin, check B12 yearly. For pregnancy planning in women with diabetes, folic acid 400–800 mcg/day is standard regardless of metformin.

Pair details →Metformin →

Label mentions16 mentions

Verbatim lines from the interaction sections, in the language of the label

From this drug’s label

  • «Medicamentos afectados por la administración concomitante de ácido fólico: La toxicidad del fluorouracilo y de los profármacos de fluorouracilo puede producirse en pacientes que toman ácido fólico…»

    AEMPS, section 4.5 · Open on CIMA

  • anticonceptivos hormonalesclass named in the label
    «Fármacos que influyen en los niveles de ácido fólico: Los anticonceptivos orales, anticonvulsivos, fármacos antituberculosos, el alcohol, la glucarpidasa y los antagonistas del ácido fólico como el…»

    AEMPS, section 4.5 · Open on CIMA

  • antiepilépticosclass named in the label
    «Medicamentos afectados por la administración concomitante de ácido fólico: Los niveles séricos de los medicamentos anticonvulsivos (fenitoína, fenobarbital, primidona y posiblemente carbamazepina)…»

    AEMPS, section 4.5 · Open on CIMA

  • antiepilepticsclass named in the label
    «Drug Interactions: There is evidence that the anticonvulsant action of phenytoin is antagonized by folic acid. A patient whose epilepsy is completely controlled by phenytoin may require increased…»

    FDA, section 7 · Open on DailyMed

  • barbituratesclass named in the label
    «Drug Interactions: Folate deficiency may result from increased loss of folate, as in renal dialysis and/or interference with metabolism (e.g., folic acid antagonists such as methotrexate); the…»

    FDA, section 7 · Open on DailyMed

  • «Medicamentos afectados por la administración concomitante de ácido fólico: El ácido fólico puede potenciar la toxicidad de la capecitabina.»

    AEMPS, section 4.5 · Open on CIMA

  • «Medicamentos afectados por la administración concomitante de ácido fólico: Los niveles séricos de los medicamentos anticonvulsivos (fenitoína, fenobarbital, primidona y posiblemente carbamazepina)…»

    AEMPS, section 4.5 · Open on CIMA

  • «Fármacos que influyen en los niveles de ácido fólico: Los anticonceptivos orales, anticonvulsivos, fármacos antituberculosos, el alcohol, la glucarpidasa y los antagonistas del ácido fólico como el…»

    AEMPS, section 4.5 · Open on CIMA

  • «Drug Interactions: Folate deficiency may result from increased loss of folate, as in renal dialysis and/or interference with metabolism (e.g., folic acid antagonists such as methotrexate); the…»

    FDA, section 7 · Open on DailyMed

  • «Medicamentos afectados por la administración concomitante de ácido fólico: Los niveles séricos de los medicamentos anticonvulsivos (fenitoína, fenobarbital, primidona y posiblemente carbamazepina)…»

    AEMPS, section 4.5 · Open on CIMA

  • «Medicamentos afectados por la administración concomitante de ácido fólico: Los niveles séricos de los medicamentos anticonvulsivos (fenitoína, fenobarbital, primidona y posiblemente carbamazepina)…»

    AEMPS, section 4.5 · Open on CIMA

  • «Drug Interactions: There is evidence that the anticonvulsant action of phenytoin is antagonized by folic acid. A patient whose epilepsy is completely controlled by phenytoin may require increased…»

    FDA, section 7 · Open on DailyMed

  • «Medicamentos afectados por la administración concomitante de ácido fólico: Agentes antibacterianos del subgrupo terapéutico sulfonamidas y sulfasalazina.»

    AEMPS, section 4.5 · Open on CIMA

  • tetracyclinesclass named in the label
    «Drug Interactions: False low serum and red cell folate levels may occur if the patient has been taking antibiotics, such as tetracycline, which suppress the growth of Lactobacillus casei.»

    FDA, section 7 · Open on DailyMed

  • «Fármacos que influyen en los niveles de ácido fólico: Los anticonceptivos orales, anticonvulsivos, fármacos antituberculosos, el alcohol, la glucarpidasa y los antagonistas del ácido fólico como el…»

    AEMPS, section 4.5 · Open on CIMA

  • «Fármacos que influyen en los niveles de ácido fólico: Los anticonceptivos orales, anticonvulsivos, fármacos antituberculosos, el alcohol, la glucarpidasa y los antagonistas del ácido fólico como el…»

    AEMPS, section 4.5 · Open on CIMA

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Folic acid used for?

Folic acid is evaluated for the following indications with varying evidence strength: Methotrexate-related adverse event prevention (evidence tier A), Neural tube defect prevention (evidence tier A), Folate deficiency anaemia (evidence tier A). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Folic acid?

Common side effects of Folic acid (≥ 1 in 100): Epigastric discomfort at high doses, Altered taste. See the Safety section for uncommon and serious reactions.

Is Folic acid safe during pregnancy?

AEMPS summary of product characteristics (section 4.6): based on human experience, no risks of folic acid use in pregnancy are known, and folic acid supplements are usually beneficial. Folate deficiency not caused by drugs and abnormal folate metabolism are linked to birth defects, including some neural tube defects, and drug-induced interference with folic acid metabolism or folate deficiency early in pregnancy (anticonvulsants, some antineoplastics) leads to congenital anomalies. A lack of this vitamin or its metabolites may also be responsible for some cases of miscarriage and intrauterine growth restriction.

Is Folic acid compatible with breastfeeding?

Transfers into breast milk. Supplementation at the RDA of 500 µg is safe and encouraged.

Who should not take Folic acid?

Folic acid is contraindicated in: Hypersensitivity to folic acid; Untreated B12 deficiency anaemia (risk of masking and neurological progression); Pernicious anaemia without B12 (same reason); Malignancy (relative contraindication for high doses). Full list in the Safety section.

“folic acid is only for pregnant women”

supplementation is recommended for all women of reproductive age who may become pregnant – most unintended pregnancies are unplanned, and the critical neural tube window is the first 28 days.

“methylfolate is better than folic acid for everyone”

for most women, folic acid 400 µg is fully effective. Methylfolate costs 5–10 times more without proven advantage in general populations. There may be benefit in women with homozygous MTHFR polymorphism and high homocysteine – but this is a narrow group.

“folic acid causes cancer”

there are observational data linking high doses with progression of pre-existing tumours in older adults – clinically significant effect not confirmed. In reproductive-age women at prophylactic doses, cancer risk is not increased.

Official sources

Direct links to regulator labels. Open in a new tab.

Other drugs in this group

Cyanocobalamin, Hydroxocobalamin, Iron oral (salts: sulfate, bisglycinate, fumarate, gluconate, polymaltose; heme iron polypeptide, lactoferrin), Methylcobalamin, Levomefolate (L-methylfolate, 5-MTHF), Vitamin B12 (cobalamin)